Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Cell Signaling Pathway
100%
Pulmonary Fibrosis
100%
Infection
66%
Bleomycin
33%
Lung
33%
Anti-Inflammatory Drug
16%
Public Health
16%
In Vitro
16%
Malignant Neoplasm
16%
Adenosine Triphosphate
16%
Tumor Necrosis Factor
16%
Analgesic Activity
16%
Phosphotransferase
16%
Phosphotransferase Inhibitor
16%
Interleukin 6
16%
Pharmacophore
16%
Pulmonary Pathology
16%
Lung Fibroblast
16%
Interleukin-1
16%
COVID-19
16%
Inflammatory Cell
16%
Cellular Infiltration
16%
Myeloperoxidase
16%
Hydroxyproline
16%
Diterpenoid
16%
Fibroblast
16%
Antiallergic Drug
16%
Myofibroblast
16%
Keyphrases
Signaling Pathway
100%
Pulmonary Fibrosis
100%
COVID-19
100%
Ovatodiolide
100%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
36%
Lung
18%
Bleomycin
18%
Public Health
9%
Collagen Deposition
9%
Analgesic Activity
9%
Anticancer
9%
Chemical Structure
9%
Interleukin-1β
9%
Interleukin-6
9%
TGF-1
9%
Dual Function
9%
Fibroblasts
9%
Inhibitory Activity
9%
Computational Analysis
9%
Kinase Inhibitor
9%
Human Lung Fibroblasts
9%
Myeloperoxidase
9%
Clinical Manifestations
9%
Pharmacophore
9%
Myofibroblast
9%
Inflammatory Cell Infiltration
9%
Inflammatory Fibrosis
9%
Pharmacological Mechanism
9%
Hydroxyproline
9%
COVID-19 Patients
9%
ATP-binding Domain
9%
Anti-allergic
9%
Persistent Inflammation
9%
Macrocyclic Diterpenes
9%
Lung Pathology
9%
3CLpro Inhibitors
9%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Fibrosis
100%
SARS Coronavirus
100%
Infection
66%
Bleomycin
33%
Anti-Inflammatory Drug
16%
Inflammation
16%
Malignant Neoplasm
16%
Analgesic Agent
16%
Adenosine Triphosphate
16%
Phosphotransferase
16%
Tumor Necrosis Factor
16%
Interleukin 6
16%
Phosphotransferase Inhibitor
16%
Myeloperoxidase
16%
Diterpenoid
16%
Hydroxyproline
16%
Antiallergic Drug
16%